Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sansom

Showing results (391-400 of 409) with videos related to

Pageof 41
Sort By:
Science Advances|May 1, 2023
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouseJames R W Conway, Sean C Warren, Young-Kyung Lee, et al.
Cell Reports|September 15, 2021
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imagingAlessia Floerchinger, Kendelle J Murphy, Sharissa L Latham, et al.
Nature Communications|December 8, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Cancer Discovery|December 17, 2020
MNK Inhibition Sensitizes <i>KRAS</i>-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC ExpressionJohn R P Knight, Constantinos Alexandrou, George L Skalka, et al.
Nature Genetics|January 8, 2021
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancerArafath K Najumudeen, Fatih Ceteci, Sigrid K Fey, et al.
Nature|November 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistanceMark White, Megan L Mills, Laura M Millett, et al.
EMBO Reports|July 23, 2025
Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapesDeclan Whyte, Sophie L Fisher, Christopher G J McKenzie, et al.
Nature Genetics|February 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancerSudhir B Malla, Ryan M Byrne, Maxime W Lafarge, et al.
Nature|February 19, 2025
Human-correlated genetic models identify precision therapy for liver cancerMiryam Müller, Stephanie May, Holly Hall, et al.
Gut|April 28, 2022
CXCR2 inhibition enables NASH-HCC immunotherapyJack Leslie, John B G Mackey, Thomas Jamieson, et al.
Pageof 41

Showing results (391-400 of 409) with videos related to

Sort By:
Pageof 41
Science Advances|May 1, 2023
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouseJames R W Conway, Sean C Warren, Young-Kyung Lee, et al.
Cell Reports|September 15, 2021
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imagingAlessia Floerchinger, Kendelle J Murphy, Sharissa L Latham, et al.
Nature Communications|December 8, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Cancer Discovery|December 17, 2020
MNK Inhibition Sensitizes <i>KRAS</i>-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC ExpressionJohn R P Knight, Constantinos Alexandrou, George L Skalka, et al.
Nature Genetics|January 8, 2021
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancerArafath K Najumudeen, Fatih Ceteci, Sigrid K Fey, et al.
Nature|November 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistanceMark White, Megan L Mills, Laura M Millett, et al.
EMBO Reports|July 23, 2025
Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapesDeclan Whyte, Sophie L Fisher, Christopher G J McKenzie, et al.
Nature Genetics|February 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancerSudhir B Malla, Ryan M Byrne, Maxime W Lafarge, et al.
Nature|February 19, 2025
Human-correlated genetic models identify precision therapy for liver cancerMiryam Müller, Stephanie May, Holly Hall, et al.
Gut|April 28, 2022
CXCR2 inhibition enables NASH-HCC immunotherapyJack Leslie, John B G Mackey, Thomas Jamieson, et al.
Pageof 41